1Anderson FA Jr,Wheeler HB,Goldberg RJ,et al.A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism:The Worcester DVT Study[J].Arch Intern Med,1991,151:933-938.
2Greerts WH,Heit JA,Clagett GP,et al.Prevention of venous thromoembolism[J].Chest,2001,119:132-135.
4Sandler DA,Martin JF.Autopsy proven pulmonary embolism in hospital patients:are we detecting enough deep vein thrombosis[J]? J R Soc Med,1989,82:203-205.
5Alikhan R,Cohen AT,Combe S,et al.Risk factors for venous thromboembolism in hospitalized patients with acute medical illness:analysis of the MEDENOX Study[J].Arch Intern Med,2004,164:963-968.
6Green KB,Silverstein RL.Hypercoagulability in cancer[J].Hematol Oncol Clin North Am,1996,10:499-530.
7Samama MM.An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients:the Sirius Study[J].Arch Intern Med,2000,160:3415-3420.
8Geerts WH,Pineo GF,Heit JA,et al.Prevention of venous thromboembolism:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126:338-400.
9Belch JJ,Lowe GD,Ward AG,et al.Prevention of deep vein thrombosis in medical patients by low-dose heparin[J].Scott Med J,1981,26:115-117.
10Clagett GP,Reisch JS.Prevention of venous thromboembolism in general surgical patients:results of meta-analysis[J].Ann Surg,1988,208:227-240.
5Turpie AG. Ptophylaxis of venous, thromboe mbolism in stroke pationts. Semin Thromb Hemost, 1997,23 : 155-157.
6Hillbom M, Efila T, Sotaniemi K, et al. Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study. Acta Neurol Scand ,2002,106 : 84-92.
7McGarry LJ, Thompson D, Weinstein MC, et al. Cost effective- ness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients . Am J Manag Care ,2004,10:632-642.
